DCM Shriram Fine Chemicals Issues Correction for Credit Rating Disclosure Filing

1 min read     Updated on 14 Apr 2026, 02:42 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

DCM Shriram Fine Chemicals Limited corrected a regulatory filing error regarding its credit rating disclosure. The company had received CARE A- stable rating for Rs. 30.00 crores long-term facilities and CARE A2+ for Rs. 17.20 crores short-term facilities, but incorrectly referenced SEBI takeover regulations instead of listing regulations in the original filing.

powered bylight_fuzz_icon
37228387

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Limited has issued a correction letter to both BSE and National Stock Exchange regarding an error in its previous credit rating disclosure filed on April 08, 2026. The company acknowledged a typographical mistake in referencing SEBI regulations in its original filing.

Credit Rating Assignment

The company had initially announced the assignment of credit ratings by CARE Ratings Limited for its various bank facilities. CARE Ratings issued a press release dated April 07, 2026, assigning credit ratings for both long-term and short-term bank facilities.

Facility/Instrument: Amount (Rs. Crores) Rating Rating Action
Long-Term Bank Facilities: 30.00 CARE A- ; stable Assigned
Short-term Bank Facilities: 17.20 CARE A2+ Assigned

Regulatory Correction

In the correction letter dated April 14, 2026, DCM Shriram Fine Chemicals acknowledged that it erroneously referenced "Regulation 30 read with Schedule III of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011" instead of the correct "Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015."

The correction letter was signed by Kokila Arora, Company Secretary & Compliance Officer (ACS 21670), and digitally submitted to both stock exchanges. The company expressed regret for the error and requested the exchanges to take the apology letter on record.

Company Information

DCM Shriram Fine Chemicals Limited is listed on BSE with Scrip Code 544703 and on National Stock Exchange with Scrip Code DSFCL. The company operates manufacturing facilities including Daurala Organics and Daurala Chemicals, located on Sardhana Road, Daurala, Meerut, Uttar Pradesh.

Will DCM Shriram Fine Chemicals seek to upgrade its CARE A- rating in the next 12-18 months as it expands its manufacturing capacity?

How might this credit rating assignment impact the company's borrowing costs and future capital expenditure plans?

Could this regulatory filing error trigger increased scrutiny from SEBI or affect the company's compliance track record?

like15
dislike

DCM Shriram Fine Chemicals Limited Submits Regulatory Compliance Certificates for Q4FY26

1 min read     Updated on 14 Apr 2026, 01:26 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

DCM Shriram Fine Chemicals Limited submitted mandatory regulatory certificates to BSE and NSE for Q4FY26 ended March 31, 2026, complying with SEBI Regulation 74(5). Company Secretary Kokila Arora communicated the submission on April 14, 2026, with certificates issued by registrar KFIN Technologies Limited confirming proper furnishing of dematerialization details to stock exchanges.

powered bylight_fuzz_icon
37698982

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Limited has fulfilled its regulatory compliance obligations by submitting mandatory certificates to stock exchanges for the quarter ended March 31, 2026. The submission ensures adherence to SEBI (Depositories & Participants) Regulations, 2018, specifically Regulation 74(5).

Regulatory Submission Details

Company Secretary Kokila Arora communicated the certificate submission to both BSE and NSE on April 14, 2026. The certificates were received from KFIN Technologies Limited, which serves as the company's Registrar and Share Transfer Agent.

Parameter: Details
Reporting Period: Quarter ended March 31, 2026
Submission Date: April 14, 2026
Regulation: SEBI Regulation 74(5)
Registrar Agent: KFIN Technologies Limited
Company Secretary: Kokila Arora (ACS 21670)

Certificate Confirmation

KFIN Technologies Limited issued certificates dated April 7, 2026, to both Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL). The certificates confirm that details of securities dematerialized and rematerialized during the quarter have been furnished to all stock exchanges where DCM Shriram Fine Chemicals Limited shares are listed.

S R Ramesh, Deputy Vice President at KFIN Technologies Limited, signed the certificates on behalf of the registrar. The certificates were addressed to the respective depositories and copied to DCM Shriram Fine Chemicals Limited's registered office in New Delhi.

Company Information

DCM Shriram Fine Chemicals Limited operates with its registered and corporate office located at 6th Floor, Kanchenjunga Building, 18, Barakhamba Road, New Delhi. The company maintains manufacturing facilities at Daurala, Meerut, including Daurala Organics and Daurala Chemicals units.

The regulatory submission demonstrates the company's commitment to maintaining transparency and compliance with SEBI regulations governing depositories and participants in the Indian securities market.

What operational or financial developments might DCM Shriram Fine Chemicals announce in their upcoming Q4 FY2026 earnings report?

How might potential changes to SEBI's depository regulations in 2026-27 affect DCM Shriram's compliance costs and reporting requirements?

Will DCM Shriram Fine Chemicals consider expanding their manufacturing capacity beyond the current Daurala facilities given their regulatory compliance track record?

like19
dislike

More News on DCM Shriram Fine Chemicals